AKINETON

This brand name is authorized in Austria, Brazil, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Germany, Ireland, Japan, Lithuania, Mexico, Netherlands, Poland, Spain, Turkey.

Active ingredients

The drug AKINETON contains one active pharmaceutical ingredient (API):

1	Biperiden UNII K35N76CUHF - BIPERIDEN HYDROCHLORIDE
	Biperiden is a predominantly centrally acting anti-cholinergic. It has a peripheral effect, which is low in comparison to atropine. Biperiden binds competitively to peripheral and central muscarinic receptors (primarily M1).
	Read more about Biperiden

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
AKINETON Tablets	MPI, EU: SmPC	European Medicines Agency (EU)
AKINETON Solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N04AA02	Biperiden	N Nervous system → N04 Anti-parkinson drugs → N04A Anticholinergic agents → N04AA Tertiary amines
Discover more medicines within N04AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	559117100007817, 559117100007907
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00660707, 00662356, 00662480, 00662528, 01607721, 01607738, 01607744, 01835066, 02033067, 02033073, 02033096, 02033104, 02126975, 02127199, 02127207, 02130497, 02237982, 02531931, 03035861, 03063969, 03063975, 03192282, 04954593, 04954601, 05023744, 06325387, 06325393, 07143493, 07143501, 07143518, 07202327, 07202333, 10353863, 10353886, 10839198, 10931188, 11229504, 15782155, 15782161, 16768507
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	364480313, 364490313
EE	Ravimiamet	1017223, 1077005
ES	Centro de información online de medicamentos de la AEMPS	26692, 28994, 51224
FI	Lääkealan turvallisuus- ja kehittämiskeskus	495152
FR	Base de données publique des médicaments	66782153
HR	Agencija za lijekove i medicinske proizvode	HR-H-140280757, HR-H-182730030
IE	Health Products Regulatory Authority	10783, 10834, 16032
JP	医薬品医療機器総合機構	1162001C1043, 1162001F1066, 1162400A1059
LT	Valstybinė vaistų kontrolės tarnyba	1010429
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	47958, 52899, 74405
NL	Z-Index G-Standaard	15137937
NL	Z-Index G-Standaard, PRK	1201, 3743
PL	Rejestru Produktów Leczniczych	100003389, 100003395, 100102660, 100164974, 100240416, 100240451, 100330898, 100333610, 100340997, 100341040, 100363892, 100366175, 100446945, 100451039, 100464388
TR	İlaç ve Tıbbi Cihaz Kurumu	8699708011528, 8699708011542, 8699708011559, 8699708011566, 8699708751530, 8699708751547